Skip to content

Funcitonality and Safety of a Knee Device for Gait Rehabilitation in Neurological Patients

Funzionalità e Sicurezza di un Dispositivo di Ginocchio Per Riabilitazione Della Deambulazione Con Pazienti Neurologici

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07670325
Acronym
AKO-R
Enrollment
20
Registered
2026-06-26
Start date
2026-06-22
Completion date
2026-11-30
Last updated
2026-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

exoskeleton, robotics rehabilitation, stroke

Brief summary

This clinical investigation aims to evaluate the safety, feasibility, and preliminary performance of the AKO-R wearable robotic device for knee assistance during walking. The study involves participants performing treadmill and overground gait training under supervised conditions, with the device providing assistive torque to support movement. Clinical and functional outcomes are assessed using validated measurement tools, while additional data are collected to characterize user performance and interaction with the device. The study is designed as an exploratory investigation to gather evidence supporting the clinical use and further development of the device. Primary outcomes regards safety of the device and preliminary clinical benefit on gait symmetry.

Detailed description

The study is structured in 5 sessions. The first and last session are the assessment. the 2nd session is the session for calibration of the exoskeleton parameters. The 3rd session is for exo familiarization and the 4th exo is for exo-assisted condition evaluation.

Interventions

DEVICEExo-Assisted

Participants perform gait training assiste by the knee exoskeletn investigational device

Sponsors

Scuola Superiore di Studi Universitari e di Perfezionamento Sant'Anna
Lead SponsorOTHER
Istituti Clinici Scientifici Maugeri SpA
CollaboratorOTHER
Fondazione Don Carlo Gnocchi Onlus
CollaboratorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* diagnosed stroke with fMRI * within 2 years from stroke event * FAC\>= 3 * height \[1.5 - 2\]m * weigth \<= 100 Kg

Exclusion criteria

* MoCA\<18 * Pregnancy * Implanted cardiac devices, such as pacemakers or implantable cardioverter defibrillators (ICDs) * Recent or current participation in research studies that, in the opinion of the Principal Investigator, may affect the subject's response to the study intervention * Severe aphasia * MAS=4

Design outcomes

Primary

MeasureTime frameDescription
Number of device-related adverse eventsthrough study completion, an average of 1 year
Step Length Symmetry Index ChangeDay 4The Step Length Symmetry Index (SI) will be compared across conditions. Descriptive data are averaged across \>20 steps. Score closer to 0 means a better outcome.
Stance Time Symmetry Index ChangeDay 4The Stance Time Symmetry Index (SI) will be compared across conditions. Descriptive data are averaged across \>20 steps. Score closer to 0 means a better outcome.

Secondary

MeasureTime frameDescription
Range of motion ChangeDay 4The Range of motion (computed as difference between minimum and maximum joint angle in a step) will be compared across conditions. Descriptive data are averaged across \>20 steps
Self-selected velocity ChangeDay 5Effect of 3 sessions on self-selected velocity, compared with Session 1. Evaluated with 10 meter walking test
EnduranceDay 5Effect of 3 sessions on endurance, compared with Session 1. Evaluated with 2 minute walking test.
Usability scoreDay 5Evaluated with System Usability Scale (SUS) questionnaire. The SUS score ranges from a minimum of 0 to a maximum of 100.
AcceptabilityDay 5Evaluated with Technology Acceptance Model (TAM) questionnaire. The TAM score goes from a minimum of 0 to a maximum score of 100.
Satisfaction ScoreDay 5Evaluated with Quebec User Evaluation of Satisfaction with assistive Technology 2.0 (QUEST 2.0). The QUEST goes from a minimum of 0 to a maximum of 100.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 27, 2026